FAM173B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.66133814775094E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.57249990806463E-10 |
Normal-vs-Stage2 |
1.71676999999315E-05 |
Normal-vs-Stage3 |
6.81865675034032E-12 |
Normal-vs-Stage4 |
1.93979998730498E-09 |
Stage1-vs-Stage2 |
6.909000E-01 |
Stage1-vs-Stage3 |
6.362400E-02 |
Stage1-vs-Stage4 |
4.105000E-01 |
Stage2-vs-Stage3 |
1.309410E-01 |
Stage2-vs-Stage4 |
3.732400E-01 |
Stage3-vs-Stage4 |
4.926000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62558855265615E-12 |
Normal-vs-AfricanAmerican |
1.89550000140315E-08 |
Normal-vs-Asian |
3.249500E-02 |
Caucasian-vs-AfricanAmerican |
9.471200E-01 |
Caucasian-vs-Asian |
6.226400E-01 |
AfricanAmerican-vs-Asian |
5.964000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.32986979603811E-14 |
Normal-vs-Female |
1.46749945528768E-10 |
Male-vs-Female |
5.125000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.80110000247424E-08 |
Normal-vs-Age(41-60Yrs) |
1.68076663698002E-12 |
Normal-vs-Age(61-80Yrs) |
1.86783921662936E-12 |
Normal-vs-Age(81-100Yrs) |
9.281500E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.351900E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.442000E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.442000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.295200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.045600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.957000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.40680000046711E-07 |
Normal-vs-Grade 2 |
9.76569936028682E-11 |
Normal-vs-Grade 3 |
2.00794936233706E-12 |
Normal-vs-Grade 4 |
1.92645899232957E-12 |
Grade 1-vs-Grade 2 |
1.629580E-01 |
Grade 1-vs-Grade 3 |
3.719200E-01 |
Grade 1-vs-Grade 4 |
9.689000E-01 |
Grade 2-vs-Grade 3 |
1.502000E-01 |
Grade 2-vs-Grade 4 |
4.499300E-03 |
Grade 3-vs-Grade 4 |
7.589500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.47140008247504E-10 |
Normal-vs-ccB subtype |
2.04639638567983E-11 |
ccA subtype-vs-ccB subtype |
1.652780E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.39670497389943E-11 |
Normal-vs-N1 |
2.4368999999913E-05 |
N0-vs-N1 |
3.195400E-01 |
|
|